Literature DB >> 2433860

Burkitt-type lymphoma. Diagnosis by fine needle aspiration cytology.

D K Das, S K Gupta, I C Pathak, S C Sharma, B N Datta.   

Abstract

Forty cases of lymphoma were categorized as Burkitt-type lymphoma in a study of fine needle aspiration (FNA) smears. These constituted 14.3% of all cases of non-Hodgkin's lymphoma diagnosed between 1974 and 1982. The median age was 22 years in these cases, 81.8% of which had extranodal tumors. The majority of the cells in the smears (59.8% +/- 8.32%) were in the 11 micron to 15 micron size range and 60.3% +/- 10.3% had noncleaved nuclei. An average 71% of the cells contained cytoplasmic and/or nuclear vacuolizations. Nonneoplastic macrophages were present in the smears in 87.5% of the cases. A study of paraffin-embedded sections in 17 cases revealed the characteristic "starry-sky" appearance in 11; in 5 it was not clearly appreciated and in 1 the nonneoplastic macrophages were absent. FNA cytology was found to be quite reliable for arriving at a diagnosis of Burkitt-type lymphoma. More than 50% of the cases were managed without resort to subsequent surgical biopsy. Exploratory laparotomy was avoided in 69% of the cases having abdominal tumors.

Entities:  

Mesh:

Year:  1987        PMID: 2433860

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  4 in total

1.  AUA1: new immunocytochemical marker for detecting epithelial cells in body cavity fluids.

Authors:  G Kocjan; E Sweeney; K D Miller; L Bobrow
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

2.  Fine-needle aspiration biopsy of lymph nodes.

Authors:  R W Astarita
Journal:  West J Med       Date:  1988-11

3.  Burkitts lymphoma of the small intestine: A cytological diagnosis.

Authors:  Ritesh Sachdev
Journal:  J Cytol       Date:  2010-07       Impact factor: 1.000

4.  Contribution of Immunocytochemistry to the Diagnosis of Usual and Unusual Lymphoma Cases.

Authors:  Dilip K Das
Journal:  J Cytol       Date:  2018 Jul-Sep       Impact factor: 1.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.